Europe sets great pace in biomedical research, despite limited funding
Five key recommendations from a white paper
- Date : 07 May 2012
- Topic : Bioethics, legal and economic issues
European biomedical research is advancing at a great pace compared to the relatively small funds available, and with more funding, it could do even better. This is one of the main conclusions from a new white paper published by the European Medical Research Councils (EMRC)—the European Science Foundation's membership organization for all medical research councils in Europe.
Calling for global collaboration and cohesion in biomedical research, the white paper analyses the current state of biomedical research within Europe compared to its international collaborators, together with an assessment of new challenges faced in Europe, including changing patterns of diseases, aging populations, and the growing cost of healthcare.
The white paper makes five key recommendations that should underlie future policy and strategy for biomedical research in Europe:
Citizens and patients should be closely engaged with biomedical research.
- The results of biomedical research should be rapidly and efficiently brought to the patient.
- Biomedical research should be conducted with high quality in an open, honest, and transparent way.
- European biomedical research should be conducted within a global context.
- Investment should be increased to create the right world-class biomedical research.
Thank you for rating!
You have already rated this page, you can only rate it once!